HOME >> BIOLOGY >> NEWS
Hopkins is first US institution to obtain powerful genotyping system

otide polymorphism, or SNP (pronounced "snip"). Several million SNPs already are known.

Geneticists have successfully correlated SNPs or other mutations with the incidence of some rare diseases such as cystic fibrosis. But determining genetic contributors to and causes of such common diseases as cancer has been a difficult, piecemeal process because these conditions involve multiple genetic changes that combine to affect health or disease.

"This genotyping technology lets you rapidly survey what amounts to the entire human genome for regions linked to a condition, and then, separately, to delve into the fine detail of very small regions of DNA to figure out what's really happening," says Scott.

With the appropriate controls and experimental set-up by trained technicians, the system determines the genotypes of all the samples and produces a score that rates the accuracy of the result.

"These genotypes can then be correlated with patient characteristics, health, tissue type or whatever it is you're studying," says Aravinda Chakravarti, Ph.D., director of the McKusick-Nathans Institute. "Instead of spending years just to get genotype information across the genome, now we can spend our time analyzing the data, looking for multiple genes rather than finding them one at a time. With this system we're well on our way to being able to do large-scale studies of complex human genetic diseases and to investigating the biological basis of individuals' susceptibility to disease."

The Illumina system's BeadArray technology uses dimpled fiberoptic strands in bundles no thicker than a pencil lead, each holding tens of thousands of tiny beads. Each bead is labeled with one of up to 1,300 DNA tags to unmask the version of a specific SNP in the sample. The fiberoptic bundles are then arrayed as in a 96-well plate.

The new facility will be housed at the Johns Hopkins Bayvie
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
14-Aug-2003


Page: 1 2 3

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
8. Dr. Robot tested at Hopkins
9. From Hopkins: Children may outgrow peanut allergies
10. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine
11. Hopkins researchers find potential new treatment for children with chronic hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... , ... June 14, 2019 , ... ... Oracle Cloud customer, will deliver a joint presentation with Versiti’s CIO at the ... 16-19 at the Rosen Shingle Creek Resort. , Versiti Vice President and Chief ...
(Date:6/11/2019)... Ind. (PRWEB) , ... June 10, 2019 , ... Improved ... in the July 2019 issue of AAPS PharmSciTech. The article was published online on ... of Improved Pharma, along with Xiaoming Sean Chen of Purdue University. , The ...
(Date:6/4/2019)... Calif. (PRWEB) , ... June 04, 2019 , ... ... technologies, today announced the appointment of Susan Murphy as the new President of ... Life Sciences?owned by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... engagement, and Carilion Clinic, a national leader in opioid treatment, announced today they ... care. , Mytonomy recently deployed its virtual care platform at the ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ ... a test on mice, MSC-EVs also increased the cells’ ability to lodge into ...
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, radiation ... have led to the advent of Chimeric Antigen Receptor T (CAR T) cell therapy, ... “CARs”. The CAR enables the final product to produce chemicals in the hopes that ...
(Date:5/31/2019)... ... 2019 , ... World Compliance Seminars today announced a live ... Boston, MA. This peer recommended interactive workshop is always selected by professionals at ... off with a compendial treatment of Data Integrity fundamentals. After laying the groundwork, ...
Breaking Biology Technology:
Cached News: